Drug: FLUDARABINE Injury: Thrombotic microangiopathy Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125211841 | FLUDARABINE | Thrombotic microangiopathy | SANDOZ | 0.00 | 0 | 20160701 | GB | |
125246531 | FLUDARABINE | Thrombotic microangiopathy | ACTAVIS | 0.00 | 0 | 20160704 | GB | |
125267441 | FLUDARABINE | Thrombotic microangiopathy | ACTAVIS | 0.00 | 0 | 20160705 | GB | |
125309501 | FLUDARABINE | Thrombotic microangiopathy | TEVA | 0.00 | 0 | 20160706 | GB | |
125311601 | FLUDARABINE | Thrombotic microangiopathy | TEVA | 0.00 | 0 | 20160706 | GB | |
125311691 | FLUDARABINE | Thrombotic microangiopathy | TEVA | 0.00 | 0 | 20160706 | GB | |
125358211 | FLUDARABINE | Thrombotic microangiopathy | ACTAVIS | 0.00 | 0 | 20160707 | GB | |
126891062 | FLUDARABINE | Thrombotic microangiopathy | CIPLA | 0.00 | 0 | 20160928 | TW |
Total Records: 8 Number of Pages: 1